(2S,3R,4R,5S,6R)-2-(5-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methyl)-2,4-dimethoxyphenyl)-5-fluoro-6-(hydroxymethyl)-5-methyltetrahydro-2H-pyran-3,4-diol

ID: ALA4753488

PubChem CID: 162653958

Max Phase: Preclinical

Molecular Formula: C24H29FO8

Molecular Weight: 464.49

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cc(OC)c([C@@H]2O[C@H](CO)[C@@](C)(F)[C@H](O)[C@H]2O)cc1Cc1ccc2c(c1)OCCO2

Standard InChI:  InChI=1S/C24H29FO8/c1-24(25)20(12-26)33-22(21(27)23(24)28)15-10-14(17(29-2)11-18(15)30-3)8-13-4-5-16-19(9-13)32-7-6-31-16/h4-5,9-11,20-23,26-28H,6-8,12H2,1-3H3/t20-,21+,22+,23-,24-/m1/s1

Standard InChI Key:  WSASRWODVRTLFZ-OYTPZHDJSA-N

Molfile:  

 
     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
    3.1291   -4.7250    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.5500   -4.0083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7205   -4.0037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5500   -3.1792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2662   -4.4208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9824   -4.0083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9824   -3.1792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2662   -2.7626    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6980   -2.7688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2662   -5.2500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8302   -2.7688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6962   -4.4260    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8278   -1.9396    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4080   -3.1872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1231   -2.7775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1260   -1.9516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4077   -1.5372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6954   -1.9493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8362   -3.1924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5521   -2.7823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2609   -3.2004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2615   -1.5504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5490   -1.9621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9796   -1.9651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9749   -2.7872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6806   -3.1999    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.3955   -2.7952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4000   -1.9731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6899   -1.5558    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.8411   -1.5402    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.8424   -0.7152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9801   -1.5382    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9784   -0.7132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  2  3  1  1
  4  2  1  0
  4  8  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  1
  5 10  1  1
  4 11  1  1
  6 12  1  6
 11 13  1  0
  9 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18  9  1  0
 15 19  1  0
 19 20  1  0
 20 21  2  0
 21 25  1  0
 24 22  1  0
 22 23  2  0
 23 20  1  0
 24 25  2  0
 24 29  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 16 30  1  0
 30 31  1  0
 18 32  1  0
 32 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4753488

    ---

Associated Targets(Human)

SLC5A1 Tclin Sodium/glucose cotransporter 1 (1526 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC5A2 Tclin Sodium/glucose cotransporter 2 (2000 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 464.49Molecular Weight (Monoisotopic): 464.1846AlogP: 1.95#Rotatable Bonds: 6
Polar Surface Area: 106.84Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.46CX Basic pKa: CX LogP: 1.68CX LogD: 1.68
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.60Np Likeness Score: 0.81

References

1. Xu G,Du F,Kuo GH,Xu JZ,Liang Y,Demarest K,Gaul MD.  (2020)  5,5-Difluoro- and 5-Fluoro-5-methyl-hexose-based C-Glucosides as potent and orally bioavailable SGLT1 and SGLT2 dual inhibitors.,  30  (17): [PMID:32738984] [10.1016/j.bmcl.2020.127387]

Source